v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 193,844 $ 955,563
Short-term investments 880,662 343,248
Total cash, cash equivalents and short-term investments 1,074,506 1,298,811
Restricted cash 3,204 0
Other receivables 6,092 2,315
Prepaid expenses and other current assets 20,234 17,416
Total current assets 1,104,036 1,318,542
Property and equipment, net 62,954 53,155
Restricted cash 762 762
Equity method investment 12,486 20,306
Intangible assets 14,198 14,512
Goodwill 14,011 10,757
Other non-current assets 65,362 70,321
Total assets 1,273,809 1,488,355
Current liabilities    
Accounts payable 4,302 3,637
Accrued and other current liabilities 24,500 10,211
Total current liabilities 28,802 13,848
Stock repurchase liability 463 711
Warrant liability 24,175 44,902
Earnout shares liability 58,499 109,844
Other non-current liabilities 1,715 2,291
Total liabilities 113,654 171,596
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Preferred stock: $0.0001 par value - 100,000,000 shares authorized at September 30, 2022 and December 31, 2021. No shares issued and outstanding at September 30, 2022 and December 31, 2021. 0 0
Common stock: $0.0001 par value - 1,400,000,000 and 1,400,000,000 shares authorized, 609,566,379 and 604,174,329 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively. 60 60
Additional paid-in capital 1,837,332 1,793,431
Accumulated deficit (667,709) (476,610)
Accumulated other comprehensive loss (9,528) (122)
Total stockholders’ equity 1,160,155 1,316,759
Total liabilities and stockholders’ equity $ 1,273,809 $ 1,488,355

Source